Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 125.37 USD -1.79%
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Interest Income Expense Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Interest Income Expense
-$249.7m
CAGR 3-Years
-5%
CAGR 5-Years
-26%
CAGR 10-Years
-21%
Perrigo Company PLC
NYSE:PRGO
Interest Income Expense
-$189.4m
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Interest Income Expense
-$9.6m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
-4%
G
GH Research PLC
NASDAQ:GHRS
Interest Income Expense
$2.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Interest Income Expense
€703k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-37%
Ovoca Bio PLC
LSE:OVB
Interest Income Expense
€9k
CAGR 3-Years
-53%
CAGR 5-Years
-54%
CAGR 10-Years
-35%

See Also

What is Jazz Pharmaceuticals PLC's Interest Income Expense?
Interest Income Expense
-249.7m USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Interest Income Expense amounts to -249.7m USD.

What is Jazz Pharmaceuticals PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-21%

Over the last year, the Interest Income Expense growth was 16%. The average annual Interest Income Expense growth rates for Jazz Pharmaceuticals PLC have been -5% over the past three years , -26% over the past five years , and -21% over the past ten years .

Back to Top